Clinical Trial: Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer

U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07325214) titled 'Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer' on Jan. 06.

Brief Summary: The purpose of this Interventional clinical trial is to evaluate safety and efficacy of 'IMD10 (focused ultrasound)' in the treatment of borderline resectable pancreatic cancer or locally advanced pancreatic cancer.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Pancreatic Cancer Borderline Resectable Pancreatic Cancer Locally Advanced Pancreatic Cancer

Intervention: DEVICE: IMD10

A non-thermal/non-tissue destructive Focused Ultrasound (FUS) dev...